Envista Holdings Corp
NVST
Cena:
Valuace
0
Růst
0
Zdraví
60
Akcionáři
Akcionáři společnosti
Insider trading
Akcionáři společnosti
| Držitel | Počet akcií | Podíl společnosti | Změna % | Váha pozice v portfoliu | Prvně nakoupeno |
|---|---|---|---|---|---|
| BLACKROCK INC. | 19.5 mil | 11.32% | 0.00% | 0.01% | 2019-09-30 |
| BLACKROCK FUNDING, INC. /DE | 19.4 mil | 11.29% | 0.00% | 0.01% | 2024-09-30 |
| BLACKROCK, INC. | 17.9 mil | 10.86% | 0.00% | 0.01% | 2024-09-30 |
| VANGUARD GROUP INC | 16.1 mil | 9.58% | 0.00% | 0.01% | 2019-09-30 |
| ARIEL INVESTMENTS, LLC | 10.9 mil | 6.61% | 0.28% | 3.08% | 2020-03-31 |
| DIMENSIONAL FUND ADVISORS LP | 9.8 mil | 5.95% | 0.01% | 0.05% | 2019-12-31 |
| MORGAN STANLEY | 8.8 mil | 5.35% | 0.00% | 0.01% | 2019-09-30 |
| 7.3 mil | 4.45% | 0.00% | 0.00% | 2026-03-31 | |
| FRANKLIN RESOURCES INC | 6.9 mil | 4.19% | 0.00% | 0.04% | 2019-12-31 |
| GATES CAPITAL MANAGEMENT, INC. | 5.4 mil | 3.26% | 0.40% | 3.72% | 2021-09-30 |
| STATE STREET CORP | 5.2 mil | 3.18% | 0.00% | 0.00% | 2019-12-31 |
| ALLIANCEBERNSTEIN L.P. | 5.0 mil | 3.06% | -0.01% | 0.04% | 2019-12-31 |
| CITADEL ADVISORS LLC | 4.6 mil | 2.79% | 0.01% | 0.02% | 2019-09-30 |
| MACQUARIE GROUP LTD | 4.6 mil | 2.77% | -0.03% | 0.13% | 2020-03-31 |
| VICTORY CAPITAL MANAGEMENT INC | 4.4 mil | 2.67% | 0.00% | 0.07% | 2019-12-31 |
| FULLER & THALER ASSET MANAGEMENT, INC. | 3.8 mil | 2.30% | 0.04% | 0.32% | 2024-06-30 |
| HARRIS ASSOCIATES L P | 3.3 mil | 1.98% | -0.02% | 0.11% | 2020-03-31 |
| AMERICAN CENTURY COMPANIES INC | 3.2 mil | 1.95% | -0.01% | 0.04% | 2020-03-31 |
| GEODE CAPITAL MANAGEMENT, LLC | 3.1 mil | 1.92% | 0.00% | 0.01% | 2019-12-31 |
| JPMORGAN CHASE & CO | 2.9 mil | 1.77% | 0.00% | 0.00% | 2019-09-30 |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 2.9 mil | 1.76% | 0.00% | 0.03% | 2019-09-30 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 2.9 mil | 1.74% | 0.03% | 0.04% | 2025-06-30 |
| QUANTINNO CAPITAL MANAGEMENT LP | 2.7 mil | 1.64% | 0.03% | 0.11% | 2023-09-30 |
| AQR CAPITAL MANAGEMENT LLC | 2.6 mil | 1.59% | 0.00% | 0.03% | 2020-12-31 |
| MILLENNIUM MANAGEMENT LLC | 2.4 mil | 1.44% | 0.02% | 0.02% | 2019-09-30 |
| GOTHAM ASSET MANAGEMENT, LLC | 2.3 mil | 1.39% | 0.07% | 0.18% | 2020-12-31 |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2.2 mil | 1.34% | 0.03% | 0.66% | 2024-09-30 |
| BANK OF AMERICA CORP /DE/ | 2.2 mil | 1.33% | 0.00% | 0.00% | 2019-09-30 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 2.1 mil | 1.30% | 0.00% | 0.01% | 2019-12-31 |
| RIVER ROAD ASSET MANAGEMENT, LLC | 2.2 mil | 1.26% | -0.12% | 0.52% | 2023-12-31 |
| NORGES BANK | 2.1 mil | 1.24% | 0.00% | 0.00% | 2025-12-31 |
| NORTHERN TRUST CORP | 1.6 mil | 0.98% | 0.00% | 0.01% | 2019-12-31 |
| PZENA INVESTMENT MANAGEMENT LLC | 1.6 mil | 0.98% | -0.02% | 0.13% | 2024-12-31 |
| ROYAL BANK OF CANADA | 1.6 mil | 0.94% | 0.00% | 0.01% | 2019-09-30 |
| SWEDBANK AB | 1.6 mil | 0.93% | -0.04% | 0.04% | 2024-03-31 |
| HOLOCENE ADVISORS, LP | 1.6 mil | 0.93% | -0.03% | 0.07% | 2025-06-30 |
| INVESCO LTD. | 1.5 mil | 0.92% | 0.00% | 0.01% | 2019-12-31 |
| TWEEDY, BROWNE CO LLC | 1.4 mil | 0.87% | 0.37% | 2.90% | 2024-03-31 |
| FRONTIER CAPITAL MANAGEMENT CO LLC | 1.4 mil | 0.87% | 0.03% | 0.37% | 2020-03-31 |
| PARADICE INVESTMENT MANAGEMENT LLC | 1.4 mil | 0.86% | -0.52% | 6.71% | 2020-03-31 |
| NUANCE INVESTMENTS, LLC | 1.5 mil | 0.85% | -2.08% | 1.66% | 2023-09-30 |
| JUPITER ASSET MANAGEMENT LTD | 1.4 mil | 0.84% | -0.16% | 0.19% | 2024-06-30 |
| FREESTONE GROVE PARTNERS LP | 1.3 mil | 0.81% | 0.21% | 0.21% | 2025-12-31 |
| LAZARD ASSET MANAGEMENT LLC | 1.3 mil | 0.80% | -0.25% | 0.04% | 2019-09-30 |
| BANK OF NEW YORK MELLON CORP | 1.3 mil | 0.79% | 0.00% | 0.01% | 2019-12-31 |
| SHAPIRO CAPITAL MANAGEMENT LLC | 1.3 mil | 0.78% | -0.40% | 0.88% | 2024-03-31 |
| FMR LLC | 1.2 mil | 0.76% | 0.00% | 0.00% | 2019-09-30 |
| RENAISSANCE TECHNOLOGIES LLC | 1.2 mil | 0.73% | 0.03% | 0.05% | 2023-09-30 |
| BRICKWOOD ASSET MANAGEMENT LLP | 1.2 mil | 0.72% | -11.96% | 17.41% | 2024-12-31 |
| IRON TRIANGLE PARTNERS LP | 1.2 mil | 0.72% | 2.95% | 2.95% | 2024-09-30 |
| FIRST TRUST ADVISORS LP | 1.2 mil | 0.72% | 0.01% | 0.03% | 2020-03-31 |
| CLARKSTON CAPITAL PARTNERS, LLC | 1.2 mil | 0.72% | 0.17% | 2.29% | 2024-03-31 |
| BALYASNY ASSET MANAGEMENT L.P. | 1.2 mil | 0.70% | 0.03% | 0.03% | 2022-09-30 |
| ARTISAN PARTNERS LIMITED PARTNERSHIP | 1.1 mil | 0.68% | -0.01% | 0.04% | 2022-03-31 |
| POLAR ASSET MANAGEMENT PARTNERS INC. | 1.1 mil | 0.65% | 0.02% | 0.34% | 2021-06-30 |
| VARENNE CAPITAL PARTNERS | 1.1 mil | 0.64% | 6.48% | 6.48% | 2026-03-31 |
| QUBE RESEARCH & TECHNOLOGIES LTD | 1.1 mil | 0.62% | -0.04% | 0.04% | 2023-12-31 |
| VANGUARD FIDUCIARY TRUST CO | 1.0 mil | 0.62% | 0.01% | 0.01% | 2026-03-31 |
| POINT72 ASSET MANAGEMENT, L.P. | 1.0 mil | 0.62% | -0.08% | 0.04% | 2024-09-30 |
| SEI INVESTMENTS CO | 1.1 mil | 0.61% | 0.00% | 0.02% | 2019-09-30 |
| PALISADE CAPITAL MANAGEMENT, LP | 995.09 tis | 0.61% | 0.15% | 0.84% | 2022-09-30 |
| ROYCE & ASSOCIATES LP | 978.45 tis | 0.60% | 0.03% | 0.25% | 2023-12-31 |
| DEUTSCHE BANK AG\ | 939.39 tis | 0.56% | 0.01% | 0.01% | 2019-09-30 |
| RUSSELL INVESTMENTS GROUP, LTD. | 914.05 tis | 0.56% | 0.02% | 0.02% | 2019-12-31 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 879.53 tis | 0.53% | 0.00% | 0.02% | 2021-06-30 |
| GOLDMAN SACHS GROUP INC | 850.44 tis | 0.52% | 0.00% | 0.00% | 2019-09-30 |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 844.06 tis | 0.51% | -0.01% | 0.03% | 2019-09-30 |
| BARCLAYS PLC | 841.62 tis | 0.49% | 0.00% | 0.00% | 2022-03-31 |
| PACER ADVISORS, INC. | 808.26 tis | 0.48% | -0.02% | 0.04% | 2022-12-31 |
| UBS GROUP AG | 780.96 tis | 0.48% | 0.00% | 0.00% | 2019-09-30 |
| DIAMOND HILL CAPITAL MANAGEMENT INC | 776.61 tis | 0.46% | -0.01% | 0.07% | 2023-12-31 |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | 786.76 tis | 0.46% | 0.00% | 0.05% | 2024-09-30 |
| CAPRICORN FUND MANAGERS LTD | 746.20 tis | 0.45% | 2.95% | 2.95% | 2026-03-31 |
| VAN LANSCHOT KEMPEN INVESTMENT MANAGEMENT N.V. | 741.49 tis | 0.45% | -0.02% | 0.17% | 2023-12-31 |
| MARATHON ASSET MANAGEMENT LTD | 723.15 tis | 0.44% | 0.17% | 0.70% | 2023-12-31 |
| TREXQUANT INVESTMENT LP | 713.25 tis | 0.43% | 0.06% | 0.13% | 2022-12-31 |
| PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO | 723.84 tis | 0.43% | 0.07% | 0.08% | 2019-12-31 |
| PARKMAN HEALTHCARE PARTNERS LLC | 711.69 tis | 0.43% | 1.86% | 1.86% | 2026-03-31 |
| INVENOMIC CAPITAL MANAGEMENT LP | 730.74 tis | 0.43% | 0.04% | 0.59% | 2023-12-31 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 729.77 tis | 0.42% | -0.05% | 0.09% | 2020-09-30 |
| OBERWEIS ASSET MANAGEMENT INC/ | 665.40 tis | 0.40% | 0.50% | 0.50% | 2026-03-31 |
| ARROWMARK COLORADO HOLDINGS LLC | 663.64 tis | 0.40% | 0.13% | 0.45% | 2024-09-30 |
| JANE STREET GROUP, LLC | 639.85 tis | 0.39% | 0.00% | 0.00% | 2019-12-31 |
| AMERIPRISE FINANCIAL INC | 619.86 tis | 0.38% | 0.00% | 0.00% | 2019-09-30 |
| WELLINGTON MANAGEMENT GROUP LLP | 625.88 tis | 0.37% | 0.00% | 0.00% | 2025-06-30 |
| MAN GROUP PLC | 628.93 tis | 0.37% | -0.02% | 0.03% | 2020-12-31 |
| RAYMOND JAMES FINANCIAL INC | 620.30 tis | 0.36% | 0.00% | 0.00% | 2024-12-31 |
| MARSHALL WACE, LLP | 614.49 tis | 0.36% | -0.01% | 0.01% | 2023-03-31 |
| D. E. SHAW & CO., INC. | 608.88 tis | 0.35% | -0.01% | 0.01% | 2023-12-31 |
| LIGHTROCK NETHERLANDS B.V. | 591.31 tis | 0.35% | -0.06% | 2.68% | 2024-12-31 |
| WELLS FARGO & COMPANY/MN | 600.00 tis | 0.35% | 0.00% | 0.00% | 2024-12-31 |
| ALLIANZ ASSET MANAGEMENT GMBH | 568.99 tis | 0.34% | 0.00% | 0.01% | 2024-12-31 |
| PRINCIPAL FINANCIAL GROUP INC | 572.39 tis | 0.33% | 0.00% | 0.01% | 2021-12-31 |
| DAVENPORT & CO LLC | 550.00 tis | 0.33% | 0.09% | 0.09% | 2023-12-31 |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 523.66 tis | 0.30% | -0.02% | 0.03% | 2023-09-30 |
| INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 500.00 tis | 0.30% | -0.22% | 0.54% | 2025-09-30 |
| HEARTLAND ADVISORS INC | 509.83 tis | 0.30% | -0.01% | 0.55% | 2024-12-31 |
| RETIREMENT SYSTEMS OF ALABAMA | 498.77 tis | 0.29% | 0.00% | 0.04% | 2021-06-30 |
| JANUS HENDERSON GROUP PLC | 475.82 tis | 0.29% | -0.01% | 0.00% | 2019-12-31 |
| NUVEEN ASSET MANAGEMENT, LLC | 496.76 tis | 0.29% | 0.00% | 0.00% | 2019-09-30 |
| LEEWARD INVESTMENTS, LLC - MA | 486.27 tis | 0.29% | 0.02% | 0.53% | 2022-03-31 |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 484.66 tis | 0.29% | 0.08% | 0.08% | 2025-06-30 |
| UBS ASSET MANAGEMENT AMERICAS INC | 463.18 tis | 0.28% | 0.00% | 0.00% | 2020-03-31 |
| RHUMBLINE ADVISERS | 471.15 tis | 0.27% | 0.00% | 0.01% | 2019-12-31 |
| NEW YORK STATE COMMON RETIREMENT FUND | 451.62 tis | 0.27% | 0.00% | 0.01% | 2019-12-31 |
| RAYMOND JAMES & ASSOCIATES | 422.78 tis | 0.25% | -0.01% | 0.01% | 2021-03-31 |
| WINTON GROUP LTD | 421.16 tis | 0.24% | 0.11% | 0.58% | 2024-06-30 |
| TUDOR INVESTMENT CORP ET AL | 393.36 tis | 0.23% | 0.01% | 0.03% | 2023-06-30 |
| ENGINEERS GATE MANAGER LP | 359.16 tis | 0.22% | 0.02% | 0.20% | 2022-03-31 |
| LEGAL & GENERAL GROUP PLC | 358.74 tis | 0.21% | 0.00% | 0.00% | 2019-09-30 |
| SWISS NATIONAL BANK | 338.50 tis | 0.20% | 0.00% | 0.00% | 2019-12-31 |
| QUANTBOT TECHNOLOGIES LP | 326.65 tis | 0.19% | 0.03% | 0.26% | 2023-06-30 |
| AXA S.A. | 326.00 tis | 0.19% | 0.00% | 0.02% | 2021-06-30 |
| HSBC HOLDINGS PLC | 299.79 tis | 0.18% | 0.00% | 0.00% | 2023-03-31 |
| M&G PLC | 306.25 tis | 0.18% | 0.00% | 0.02% | 2024-03-31 |
| POLAR CAPITAL HOLDINGS PLC | 275.34 tis | 0.17% | -0.04% | 0.03% | 2020-12-31 |
| EDGESTREAM PARTNERS, L.P. | 272.51 tis | 0.16% | -0.03% | 0.29% | 2023-06-30 |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM | 274.73 tis | 0.16% | 0.00% | 0.00% | 2019-12-31 |
Insider trading
| Jméno | Pozice | Typ transakce | Počet převedených akcií | Průměrná cena akcie | Datum | Počet držených akcií |
|---|---|---|---|---|---|---|
| Keel Paul A | director, officer: Chief Executive Officer | F-InKind | 12811 | 23.43 | 27.5 2026 | 371574 |
| Huennekens R Scott | director | A-Award | 12585 | 0.00 | 21.5 2026 | 82105 |
| Raskas Daniel | director | A-Award | 9330 | 0.00 | 21.5 2026 | 54010 |
| Pierce James Andrew | director | A-Award | 9330 | 0.00 | 21.5 2026 | 18485 |
| GALLAHUE KIERAN | director | A-Award | 9330 | 0.00 | 21.5 2026 | 54010 |
| Jain Vivek | director | A-Award | 9330 | 0.00 | 21.5 2026 | 52945 |
| TSINGOS CHRISTINE A | director | A-Award | 9330 | 0.00 | 21.5 2026 | 59930 |
| Carruthers Wendy | director | A-Award | 9330 | 0.00 | 21.5 2026 | 59940 |
| Befidi Robert | officer: President, Diagnostics | A-Award | 13845 | 0.00 | 27.2 2026 | 13845 |
| Befidi Robert | officer: President, Diagnostics | A-Award | 18020 | 29.59 | 27.2 2026 | 18020 |
| Befidi Robert | officer: President, Diagnostics | F-InKind | 2177 | 29.59 | 27.2 2026 | 43327 |
| Befidi Robert | officer: President, Diagnostics | A-Award | 7605 | 0.00 | 27.2 2026 | 50932 |
| Keel Paul A | director, officer: Chief Executive Officer | A-Award | 115320 | 29.59 | 27.2 2026 | 115320 |
| Keel Paul A | director, officer: Chief Executive Officer | A-Award | 132885 | 0.00 | 27.2 2026 | 132885 |
| Keel Paul A | director, officer: Chief Executive Officer | F-InKind | 11840 | 29.59 | 27.2 2026 | 335715 |
| Keel Paul A | director, officer: Chief Executive Officer | A-Award | 48670 | 0.00 | 27.2 2026 | 384385 |
| Kaabi Faez C | officer: Chief Accounting Officer | F-InKind | 4964 | 29.59 | 27.2 2026 | 45032 |
| Kaabi Faez C | officer: Chief Accounting Officer | A-Award | 13520 | 0.00 | 27.2 2026 | 58552 |
| Nance Mark E | officer: General Counsel | A-Award | 23070 | 0.00 | 27.2 2026 | 23070 |
| Nance Mark E | officer: General Counsel | A-Award | 30040 | 29.59 | 27.2 2026 | 30040 |
| Nance Mark E | officer: General Counsel | F-InKind | 3368 | 29.59 | 27.2 2026 | 68577 |
| Nance Mark E | officer: General Counsel | A-Award | 12675 | 0.00 | 27.2 2026 | 81252 |
| Reis Mischa | officer: SVP, Strategy & Bus. Dev. | A-Award | 10770 | 0.00 | 27.2 2026 | 10770 |
| Reis Mischa | officer: SVP, Strategy & Bus. Dev. | A-Award | 14020 | 29.59 | 27.2 2026 | 14020 |
| Reis Mischa | officer: SVP, Strategy & Bus. Dev. | F-InKind | 2976 | 29.59 | 27.2 2026 | 29406 |
| Reis Mischa | officer: SVP, Strategy & Bus. Dev. | A-Award | 5915 | 0.00 | 27.2 2026 | 35321 |
| Nilsson Stefan | officer: President, Nobel Biocare | A-Award | 13845 | 0.00 | 27.2 2026 | 13845 |
| Nilsson Stefan | officer: President, Nobel Biocare | A-Award | 18020 | 29.59 | 27.2 2026 | 18020 |
| Nilsson Stefan | officer: President, Nobel Biocare | F-InKind | 182 | 29.59 | 27.2 2026 | 54759 |
| Nilsson Stefan | officer: President, Nobel Biocare | A-Award | 7605 | 0.00 | 27.2 2026 | 62364 |
| Acurio Veronica | officer: President, Orthodontics | A-Award | 13845 | 0.00 | 27.2 2026 | 13845 |
| Acurio Veronica | officer: President, Orthodontics | A-Award | 18020 | 29.59 | 27.2 2026 | 18020 |
| Acurio Veronica | officer: President, Orthodontics | F-InKind | 1412 | 29.59 | 27.2 2026 | 48911 |
| Acurio Veronica | officer: President, Orthodontics | A-Award | 7605 | 0.00 | 27.2 2026 | 56516 |
| Hammes Eric D. | officer: Chief Financial Officer | A-Award | 29225 | 0.00 | 27.2 2026 | 29225 |
| Hammes Eric D. | officer: Chief Financial Officer | A-Award | 38040 | 29.59 | 27.2 2026 | 38040 |
| Hammes Eric D. | officer: Chief Financial Officer | F-InKind | 2045 | 29.59 | 27.2 2026 | 94743 |
| Hammes Eric D. | officer: Chief Financial Officer | A-Award | 16055 | 0.00 | 27.2 2026 | 110798 |
| Reis Mischa | officer: SVP, Strategy & Bus. Dev. | M-Exempt | 4041 | 19.04 | 11.2 2026 | 0 |
| Reis Mischa | officer: SVP, Strategy & Bus. Dev. | M-Exempt | 5634 | 15.97 | 11.2 2026 | 0 |
| Reis Mischa | officer: SVP, Strategy & Bus. Dev. | S-Sale | 5634 | 30.00 | 11.2 2026 | 32382 |
| Reis Mischa | officer: SVP, Strategy & Bus. Dev. | M-Exempt | 4041 | 19.04 | 11.2 2026 | 36423 |
| Reis Mischa | officer: SVP, Strategy & Bus. Dev. | M-Exempt | 5634 | 15.97 | 11.2 2026 | 38016 |
| Acurio Veronica | officer: President, Orthodontics | A-Award | 998 | 0.00 | 3.2 2026 | 998 |
| Kaabi Faez C | officer: Chief Accounting Officer | A-Award | 1186 | 0.00 | 3.2 2026 | 5040 |
| Nance Mark E | officer: General Counsel | A-Award | 2006 | 0.00 | 3.2 2026 | 7587 |
| Keel Paul A | director, officer: Chief Executive Officer | A-Award | 4091 | 0.00 | 3.2 2026 | 4091 |
| Hammes Eric D. | officer: Chief Financial Officer | A-Award | 1119 | 0.00 | 3.2 2026 | 1119 |
| Reis Mischa | officer: SVP, Strategy & Bus. Dev. | A-Award | 2919 | 0.00 | 3.2 2026 | 29357 |
| Befidi Robert | officer: President, Diagnostics | A-Award | 998 | 0.00 | 3.2 2026 | 2149 |
| Keel Paul A | director, officer: Chief Executive Officer | F-InKind | 54097 | 20.35 | 4.11 2025 | 347555 |
| Reis Mischa | officer: SVP, Strategy & Bus. Dev. | S-Sale | 15000 | 21.60 | 27.8 2025 | 32382 |
| Acurio Veronica | officer: President, Orthodontics | F-InKind | 5422 | 21.12 | 27.8 2025 | 50323 |
| Nilsson Stefan | officer: President, Nobel Biocare | F-InKind | 804 | 21.12 | 27.8 2025 | 54941 |
| Hammes Eric D. | officer: Chief Financial Officer | F-InKind | 7654 | 21.12 | 27.8 2025 | 96788 |
| Befidi Robert | officer: President, Diagnostics | F-InKind | 3454 | 21.12 | 27.8 2025 | 45504 |
| Pierce James Andrew | director: | 0 | 0.00 | 16.7 2025 | 0 | |
| Pierce James Andrew | director | A-Award | 9155 | 0.00 | 16.7 2025 | 9155 |
| Huennekens R Scott | director | A-Award | 14370 | 0.00 | 12.6 2025 | 69520 |
| Hulit Barbara B. | director | A-Award | 10450 | 0.00 | 12.6 2025 | 79820 |
| TSINGOS CHRISTINE A | director | A-Award | 10450 | 0.00 | 12.6 2025 | 50600 |
| Carruthers Wendy | director | A-Award | 10450 | 0.00 | 12.6 2025 | 50610 |
| Jain Vivek | director | A-Award | 10450 | 0.00 | 12.6 2025 | 43615 |
| Raskas Daniel | director | A-Award | 10450 | 0.00 | 12.6 2025 | 44680 |
| GALLAHUE KIERAN | director | A-Award | 10450 | 0.00 | 12.6 2025 | 44680 |
| Keel Paul A | director, officer: Chief Executive Officer | F-InKind | 12787 | 16.72 | 27.5 2025 | 401652 |
| Nance Mark E | officer: General Counsel | A-Award | 33455 | 0.00 | 27.2 2025 | 33455 |
| Nance Mark E | officer: General Counsel | A-Award | 42370 | 20.66 | 27.2 2025 | 42370 |
| Nance Mark E | officer: General Counsel | F-InKind | 3691 | 20.66 | 27.2 2025 | 53790 |
| Nance Mark E | officer: General Counsel | A-Award | 18155 | 0.00 | 27.2 2025 | 71945 |
| Hammes Eric D. | officer: Chief Financial Officer | A-Award | 28995 | 0.00 | 27.2 2025 | 28995 |
| Hammes Eric D. | officer: Chief Financial Officer | A-Award | 36720 | 20.66 | 27.2 2025 | 36720 |
| Hammes Eric D. | officer: Chief Financial Officer | A-Award | 15735 | 0.00 | 27.2 2025 | 104442 |
| Befidi Robert | officer: President, Diagnostics | A-Award | 18960 | 0.00 | 27.2 2025 | 18960 |
| Befidi Robert | officer: President, Diagnostics | A-Award | 24010 | 20.66 | 27.2 2025 | 24010 |
| Befidi Robert | officer: President, Diagnostics | F-InKind | 1123 | 20.66 | 27.2 2025 | 38668 |
| Befidi Robert | officer: President, Diagnostics | A-Award | 10290 | 0.00 | 27.2 2025 | 48958 |
| Nilsson Stefan | officer: President, Nobel Biocare | A-Award | 18960 | 0.00 | 27.2 2025 | 18960 |
| Nilsson Stefan | officer: President, Nobel Biocare | A-Award | 24010 | 20.66 | 27.2 2025 | 24010 |
| Nilsson Stefan | officer: President, Nobel Biocare | A-Award | 10290 | 0.00 | 27.2 2025 | 55745 |
| Acurio Veronica | officer: President, Orthodontics | A-Award | 18960 | 0.00 | 27.2 2025 | 18960 |
| Acurio Veronica | officer: President, Orthodontics | A-Award | 24010 | 20.66 | 27.2 2025 | 24010 |
| Acurio Veronica | officer: President, Orthodontics | A-Award | 10290 | 0.00 | 27.2 2025 | 55745 |
| Keel Paul A | director, officer: Chief Executive Officer | A-Award | 153660 | 20.66 | 27.2 2025 | 153660 |
| Keel Paul A | director, officer: Chief Executive Officer | A-Award | 181985 | 0.00 | 27.2 2025 | 181985 |
| Keel Paul A | director, officer: Chief Executive Officer | A-Award | 65830 | 0.00 | 27.2 2025 | 414439 |
| Reis Mischa | officer: SVP, Strategy & Bus. Dev. | A-Award | 15615 | 0.00 | 27.2 2025 | 15615 |
| Reis Mischa | officer: SVP, Strategy & Bus. Dev. | A-Award | 19780 | 20.66 | 27.2 2025 | 19780 |
| Reis Mischa | officer: SVP, Strategy & Bus. Dev. | F-InKind | 3813 | 20.66 | 27.2 2025 | 38907 |
| Reis Mischa | officer: SVP, Strategy & Bus. Dev. | A-Award | 8475 | 0.00 | 27.2 2025 | 47382 |
| Kaabi Faez C | officer: Chief Accounting Officer | A-Award | 22600 | 20.66 | 27.2 2025 | 22600 |
| Kaabi Faez C | officer: Chief Accounting Officer | F-InKind | 4319 | 20.66 | 27.2 2025 | 40311 |
| Kaabi Faez C | officer: Chief Accounting Officer | A-Award | 9685 | 0.00 | 27.2 2025 | 49996 |
| Reis Mischa | officer: SVP, Strategy & Bus. Dev. | A-Award | 3152 | 0.00 | 4.2 2025 | 26438 |
| Kaabi Faez C | officer: Chief Accounting Officer | A-Award | 689 | 0.00 | 4.2 2025 | 3854 |
| Nance Mark E | officer: General Counsel | A-Award | 965 | 0.00 | 4.2 2025 | 5581 |
| Befidi Robert | officer: President, Diagnostics | A-Award | 1151 | 0.00 | 4.2 2025 | 1151 |
| Acurio Veronica | officer: President, Orthodontics | 0 | 0.00 | 25.11 2024 | 45455 | |
| Nilsson Stefan | officer: President, Nobel Biocare | 0 | 0.00 | 25.11 2024 | 45455 | |
| Keel Paul A | director, officer: Chief Executive Officer | F-InKind | 53996 | 20.94 | 4.11 2024 | 348609 |
